002100.SZ
天康生物
SZSE · Consumer Defensive · C 制造业 · CN
CNY 7.17
+0.28%Year over year
Reported trailing growth
- Revenue
- -4.9%
- EBITDA
- —
- EBIT
- -98.2%
- EPS
- —
- Free cash flow
- -42.5%
- Operating cash flow
- -39.0%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -0.0%
- EBITDA
- +0.5%
- EBIT
- +7.9%
- Net income
- -9.1%
- EPS
- -10.6%
- Free cash flow
- -95.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026